This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Last revision Both sides next revision | ||
keller_and_evans_lab:gscan [2016/10/24 16:25] scott |
keller_and_evans_lab:gscan [2019/10/28 15:59] lessem ↷ Page moved from gscan to keller_and_evans_lab:gscan |
||
---|---|---|---|
Line 29: | Line 29: | ||
======= GSCAN GWAS ======= | ======= GSCAN GWAS ======= | ||
+ | |||
+ | |||
+ | ====== Workgroups ====== | ||
+ | |||
+ | * **Phenotype workgroup: | ||
+ | * **Analysis workgroup: | ||
Line 65: | Line 71: | ||
====== TOPMed ====== | ====== TOPMed ====== | ||
+ | |||
+ | We hope to update this section with detailed descriptions of how we have conducted phenotype derivations for each TOPMed cohort to which we have access to raw data. | ||
+ | |||
+ | * For now, the R scripts to go from source phenotype file to eventual derived phenotype is located here: | ||
+ | / | ||
+ | |||
+ | * We're tracking analyses in [[https:// | ||
- | ===== Phenotype definitions and analysis plan ===== | + | ===== Phenotype definitions and analysis plan for external studies |
Phenotype definitions and analysis plans for the TOPMed studies are {{file_topmed_smoking_analysis_plan-v0_2.docxcontained in this document}}. | Phenotype definitions and analysis plans for the TOPMed studies are {{file_topmed_smoking_analysis_plan-v0_2.docxcontained in this document}}. | ||
Line 77: | Line 90: | ||
- | While authorship is decided on an individual basis for each paper (depending on contribution), typically, authorship is arranged in groups. We hope the GIANT investigators will forgive us for adopting their authorship guidelines. | + | While authorship is decided on an individual basis for each GSCAN paper, typically, authorship is arranged in groups. We hope the GIANT investigators will forgive us for adopting their authorship guidelines. |
* A group of 6 or fewer junior investigators who strongly led the efforts, usually starred to denote equal contribution, | * A group of 6 or fewer junior investigators who strongly led the efforts, usually starred to denote equal contribution, |